ClinicalTrials.gg
Not yet recruitingNCT07157293Online MotUpdated Oct 13, 2026

Online Intervention To Improve Motivation

An interventional study of Online Motivation Enhancing Intervention in Schizophrenia Prodromal, SCHIZOPHRENIA 1 (Disorder) and Psychosis, sponsored by University of Alabama at Birmingham. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Treatment

How we know

Updated Oct 13, 2026Start date movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Non-randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 20 studies in Schizotypal Personality Disorder with a site in United States — 3 open to participants now, 5 under way, none of them phase 3. Schizotypal Personality Disorder · United States.

Planned enrollment
6th of 17
60 · median 45
Started
2026
the only one that year
No phase
12 of 20
2 open now
Registered
20th of 20
by date

Among the 20 studies in Schizotypal Personality Disorder with a site in United States, this one is the 6th largest by planned enrollment of the 17 interventional ones that give a count, is the only one that started in 2026, is one of 12 with no phase, and was the 20th registered.

Schizotypal Personality Disorder

49 studies on the registry are indexed under Schizotypal Personality Disorder; 12 are open to participants now.

Browse Schizotypal Personality Disorder studies →

Open to participants now

3 of the 20 studies in Schizotypal Personality Disorder with a site in United States are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 9 Schizotypal Personality Disorder studies recruiting now, 1 sets no upper age limit and 8 stop at 75 or younger; 5 take children under 18; 2 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 20 studies in Schizotypal Personality Disorder with a site in United States, or all of them as a file.
02

Study summary

Participants will complete one online intervention lasting 12 weeks. Each week, they will be asked to complete a 20-30 minute session online. The intervention is targeting improved mood and positive affect in order to support increases in motivation and goal-directed behavior. Before and after the intervention, participants will be asked to complete measures to assess symptoms, mood, and behavior.

03

Conditions studied

  • Schizophrenia Prodromal
  • SCHIZOPHRENIA 1 (Disorder)
  • Psychosis

Keywords

  • negative symptoms
  • schizophrenia
  • psychosis
  • digital health
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of schizophrenia or a related psychotic disorder
  • Meeting criteria for being at clinical high risk for psychosis

Exclusion criteria

Exclusion Criteria:

  • Does not have access to a computer each week
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Online Motivation Focused Intervention

    Behavioral: Online Motivation Enhancing Intervention

Interventions

  • BehavioralOnline Motivation Enhancing Intervention

    This is a online intervention that will ask participants to review and complete 30 minutes of material each week.

06

What researchers measure

Primary outcomes

  1. Brief Negative Symptom Scale

    Interview measure of motivation and pleasure

    Time frame: immediately before and after the intervention

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2026; primary completion for May 2028, 17 months later.

Of 20 interventional studies with no phase under Schizotypal Personality Disorder, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 59. This study's planned 17 months is below that.

Start moved once since we started tracking on Sep 25, 2026: Aug 2026 → Dec 2026, on Oct 13, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 25, 2025
First posted
Sep 5, 2025
StartEst.
Dec 2026was Aug 2026
Primary completionEst.
May 2028
CompletionEst.
Aug 2028
Last update
Oct 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Aug 2026→Dec 2026
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    Start date Aug 2026→Dec 2026
    + 2 other changes: identifiers and verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07157293
Responsible party
Lauren Luther (Assistant Professor, University of Alabama at Birmingham) — Principal investigator
First posted
Sep 5, 2025
Start date
Dec 2026 (estimated)
Primary completion
May 2028 (estimated)
Completion
Aug 2028 (estimated)
Last update
Oct 13, 2026

Study contacts

Lauren Luther
Contact
cas-treatlab@uab.edu
205-530-1117

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion